NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants. - Poh XY; Mah SYY; Yeoh AYY; Chavatte JM; Lim DRX; Tan CCY; Tang HL; Gandhi M; Rahman N; Rao S; Chia PY; Sadarangani SP; et al. (Human vaccines & immunotherapeutics, 2026)